$SIBN

Impax Asset Management Group plc Has $23.66 Million Stock Holdings in SiBone $SIBN

Impax Asset Management Group plc increased its stake in SiBone (NASDAQ:SIBN) by 17.1% in the fourth quarter, bringing their total holdings to $23.66 million. Other institutional investors have also adjusted their positions in SiBone, with 98.11% of the stock owned by institutional investors and hedge funds. Despite some insider selling, analysts maintain a "Moderate Buy" consensus rating for SiBone, with an average target price of $24.00.

Original reporting
MarketBeat · MarketBeat
Published Apr 25, 2026, 12:54 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 25, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Impax Asset Management Group plc Has $23.66 Million Stock Holdings in SiBone $SIBN — source image
Decision brief

The 30-second read

$SIBNNeutralMed
01

Why it matters

The increased institutional stake suggests potential for price appreciation, but insider selling and moderate analyst ratings advise caution.

02

Market read

While the news indicates institutional confidence, the overall impact on SIBN's stock is moderate, and traders should consider broader market factors.

03

What to watch

Broader market volatility, sector-specific risks, or upcoming clinical trial results could influence stock performance independently of institutional activity.

Timing: short to medium term (1-3 months)

Background

Impax Asset Management increased its holdings in SiBone, a company in the life sciences sector, indicating institutional confidence amidst steady analyst ratings.

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

Significant institutional holdings increase and maintained analyst ratings suggest moderate positive sentiment.

Expected impact

Potential slight upward movement over the next 1-3 months, contingent on broader market conditions.

Evidence & confidence

Institutional buying signals confidence, but insider selling and moderate analyst ratings temper enthusiasm.

Market effects

Potential positive sentiment in the medical device and life sciences sectors due to increased institutional interest.

Limited regional impact; primarily US-based institutional activity.

Moderate; reflects institutional confidence but not a broad market shift.

Counterpoint

Institutional buying may be a defensive move or portfolio balancing rather than a bullish signal; insider selling could indicate profit-taking or concerns about short-term prospects.

Key entities

  • Impax Asset Management Group plc

    A global asset management firm with significant holdings in SIBN.

  • SiBone

    A medical device company specializing in spinal implant technologies.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

$LMTMed

Pentagon pushes military contractors to accelerate production amid shortages after war on Iran

The Pentagon ordered US defense contractors to submit within 21 days plans to accelerate production of missiles and interceptors amid shortages after the first month of strikes against Iran. It cited depleted Patriot and THAAD inventories and said framework agreements with Lockheed Martin and Northrop Grumman target PAC-3 and THAAD output. Lockheed Martin received a contract up to $58.6B to triple PAC-3 production by 2030.